Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06305234
Status:
RECRUITING
Last Update Posted:
2024-03-12
First Post:
2024-01-30
Brief Title:
A Long Term Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU PALisade
Sponsor:
BioMarin Pharmaceutical
Organization:
BioMarin Pharmaceutical
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-20
Start Date Type:
ACTUAL
Primary Completion Date:
2033-11-18
Primary Completion Date Type:
ESTIMATED
Completion Date:
2033-11-18
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-30
First Submit QC Date:
March 8 2024
Study First Post Date:
2024-03-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-23
Last Update Post Date:
2024-03-12
Last Update Post Date Type:
ACTUAL